Market Overview

UPDATE: ISI Group Initiates Allscripts Healthcare Solutions with Market Weight, $11 PT on Product Development Overhang

Share:
Related MDRX
Jefferies: 10 Buyout Targets To Own During The M&A Boom
Stifel Sees 'Limited Growth Opportunities' For Allscripts

ISI Group initiated its coverage on Allscripts Healthcare Solutions (NASDAQ: MDRX) with a rating of Market Weight and a price target of $11.

ISI Group noted, "Our thesis for MDRX is based on continued issues related to product development efforts and the overhang that this creates on bookings growth, the potential for renewed cross-sell opportunities following the product revamp, and the trade-off between cost synergies and increased R&D spending limiting margin expansion opportunities. However, with the recent sell-off in the stock, we think that the appropriate risk level is assumed in valuation and MDRX continues to have one of the largest installed bases in the market."

Allscripts Healthcare Solutions closed at $10.21 on Wednesday.

Latest Ratings for MDRX

DateFirmActionFromTo
Apr 2015Stifel NicolausInitiates Coverage onHold
Mar 2015RW BairdInitiates Coverage onOutperform
Feb 2015BarclaysMaintainsEqualweight

View More Analyst Ratings for MDRX
View the Latest Analyst Ratings

Posted-In: ISI GroupAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (MDRX)

Around the Web, We're Loving...